Lupin alliance partner Concord gets USFDA nod to generic version of CellCept Tablets Ruchika Sharma8 Aug 2020 9:30 AM ISTMumbai: Pharma major Lupin Limited in alliance with Concord Biotech Limited has announced that it has received approval from the United...
Alembic Pharma Vardenafil Hydrochloride Tablet gets USFDA nod to treat erectile dysfunction Ruchika Sharma6 Aug 2020 12:53 PM ISTVardenafil Hydrochloride Tablets are indicated for the treatment of erectile dysfunction.
Lupin gets tentative USFDA nod for diabetes drug Empagliflozin Ruchika Sharma5 Aug 2020 11:40 AM ISTMumbai, Baltimore: Pharma major Lupin Limited has announced that it has received tentative approval for its Empagliflozin Tablets, 10 mg...
Zydus Cadila gets USFDA tentative nod to market Parkinson's disease drug Ruchika Sharma3 Aug 2020 10:00 AM ISTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules (US RLD - Rytary®)...
FDA nod to Roche's Tecentriq plus Cotellic and Zelboraf in advanced melanoma Ruchika Sharma3 Aug 2020 9:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab) plus Cotellic® (cobimetinib)...
Lumos Pharma to sell its Priority Review Voucher ERVEBO to MSD Ruchika Sharma2 Aug 2020 9:30 AM ISTBased upon an agreed valuation of $100 million Merck will pay Lumos $60 million
PharmaCyte Biotech submits Drug Master File to USFDA for Pancreatic Cancer Therapy Ruchika Sharma2 Aug 2020 9:00 AM ISTLaguna Hills: PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its...
Merck HIF-2α Inhibitor MK-6482 gets Breakthrough Therapy Designation from USFDA Ruchika Sharma31 July 2020 9:00 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted...
Dr Reddy's Labs gets USFDA nod for lice treatment lotion XEGLYZE in US Ruchika Sharma28 July 2020 12:42 PM ISTXEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.
Zydus Cadila Desidustat gets USFDA nod to initiate clinical trials on cancer patients Ruchika Sharma24 July 2020 1:33 PM ISTAhmedabad: Zydus has received approval from the USFDA, to initiate clinical trials of Desidustat in Chemotherapy Induced Anemia...
Lupin gets tentative USFDA approval for diabetes drugs Empagliflozin, Linagliptin Ruchika Sharma24 July 2020 12:19 PM ISTEmpagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...
Unichem Labs irregular heartbeat drug Amiodarone gets USFDA approval Ruchika Sharma23 July 2020 12:05 PM ISTMumbai: Unichem Laboratories Limited has received ANDA approval for its Amiodarone Tablets, USP, 200 mg from the United States Food and Drug ...
